Competitive Fitness Assays Indicate that the E138A Substitution in HIV-1 Reverse Transcriptase Decreases In Vitro Susceptibility to Emtricitabine

por Sluis-Cremer, Nicolas, Huber, Kelly D., Brumme, Chanson J., Harrigan, P. Richard
Publicado 2014

Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control

por Bartha, István, McLaren, Paul J., Brumme, Chanson, Harrigan, Richard, Telenti, Amalio, Fellay, Jacques
Publicado en PLoS Comput Biol (2017)

Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB

por Dahabieh, Matthew S, Ooms, Marcel, Brumme, Chanson, Taylor, Jeremy, Harrigan, P Richard, Simon, Viviana, Sadowski, Ivan
Publicado 2014

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification

por Lima, Viviane D., Wang, Lu, Brumme, Chanson, Wu, Lang, Montaner, Julio S. G., Harrigan, P. Richard
Publicado en PLoS One (2017)

Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals

por Sakai, Keiko, Chikata, Takayuki, Brumme, Zabrina L., Brumme, Chanson J., Gatanag, Hiroyuki, Oka, Shinichi, Takiguchi, Masafumi
Publicado en Retrovirology (2015)

Erratum to: Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals

por Sakai, Keiko, Chikata, Takayuki, Brumme, Zabrina L., Brumme, Chanson J., Gatanaga, Hiroyuki, Oka, Shinichi, Takiguchi, Masafumi
Publicado en Retrovirology (2015)

Replication Fitness of Multiple Nonnucleoside Reverse Transcriptase-Resistant HIV-1 Variants in the Presence of Etravirine Measured by 454 Deep Sequencing

por Brumme, Chanson J., Huber, Kelly D., Dong, Winnie, Poon, Art F. Y., Harrigan, P. Richard, Sluis-Cremer, Nicolas
Publicado 2013

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada

por Rocheleau, Genevieve, Franco-Villalobos, Conrado, Oliveira, Natalia, Brumme, Zabrina L., Rusch, Melanie, Shoveller, Jeannie, Brumme, Chanson J., Harrigan, P. Richard
Publicado en PLoS One (2017)

Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay

por Brumme, Chanson J., Swenson, Luke C., Wynhoven, Brian, Yip, Benita, Skinner, Stuart, Lima, Viviane Dias, Montaner, Julio S. G., Harrigan, P. Richard
Publicado 2012

The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes

por Tam, Lily W. Y., Chui, Celia K. S., Brumme, Chanson J., Bangsberg, David R., Montaner, Julio S. G., Hogg, Robert S., Harrigan, P. Richard
Publicado 2008

Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resources

por McLaughlin, Angela, Sereda, Paul, Oliveira, Natalia, Barrios, Rolando, Brumme, Chanson J., Brumme, Zabrina L., Montaner, Julio S.G., Joy, Jeffrey B.
Publicado en EBioMedicine (2019)

Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort S...

por Tadesse, Birkneh Tilahun, Chala, Adugna, Mukonzo, Jackson, Chaka, Tolosssa Eticha, Tadesse, Sintayehu, Makonnen, Eyasu, Brumme, Zabrina L., Brumme, Chanson J., Aklillu, Eleni
Publicado en Pathogens (2019)

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium

por Ji, Hezhao, Sandstrom, Paul, Paredes, Roger, Harrigan, P. Richard, Brumme, Chanson J., Avila Rios, Santiago, Noguera-Julian, Marc, Parkin, Neil, Kantor, Rami
Publicado en Viruses (2020)

HIV VprR77Q mutation does not influence clinical response of individuals initiating Highly Active Antiretroviral Therapy

por Chui, Celia, Cheung, Peter K., Brumme, Chanson J., Mo, Theresa, Brumme, Zabrina L., Montaner, Julio S.G., Badley, Andrew D., Harrigan, P. Richard
Publicado 2006

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics

por Akahoshi, Tomohiro, Gatanaga, Hiroyuki, Kuse, Nozomi, Chikata, Takayuki, Koyanagi, Madoka, Ishizuka, Naoki, Brumme, Chanson J., Murakoshi, Hayato, Brumme, Zabrina L., Oka, Shinichi, Takiguchi, Masafumi
Publicado en PLoS Pathog (2020)

Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy

por Lee, Guinevere Q., Dong, Winnie, Mo, Theresa, Knapp, David J. H. F., Brumme, Chanson J., Woods, Conan K., Kanters, Steve, Yip, Benita, Harrigan, P. Richard
Publicado 2014

The Impact of Clinical, Demographic and Risk Factors on Rates of HIV Transmission: A Population-based Phylogenetic Analysis in British Columbia, Canada

por Poon, Art F. Y., Joy, Jeffrey B., Woods, Conan K., Shurgold, Susan, Colley, Guillaume, Brumme, Chanson J., Hogg, Robert S., Montaner, Julio S. G., Harrigan, P. Richard
Publicado en J Infect Dis (2015)

Discordance between Etravirine Phenotype and Genotype-Based Predicted Phenotype for Subtype C HIV-1 from First-Line Antiretroviral Therapy Failures in South Africa

por McCormick, Kevin D., Penrose, Kerri J., Brumme, Chanson J., Harrigan, P. Richard, Viana, Raquel V., Mellors, John W., Parikh, Urvi M., Wallis, Carole L.
Publicado en Antimicrob Agents Chemother (2020)

Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs

por Montoya, Vincent, Howe, Anita Y. M., Dong, Weiyan Y., Dong, Winnie, Brumme, Chanson J., Olmstead, Andrea D., Hayashi, Kanna, Richard Harrigan, P., Joy, Jeffrey B.
Publicado en Sci Rep (2021)

Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study

por Sudderuddin, Hanwei, Kinloch, Natalie N., Jin, Steven W., Miller, Rachel L., Jones, Bradley R., Brumme, Chanson J., Joy, Jeffrey B., Brockman, Mark A., Brumme, Zabrina L.
Publicado en Retrovirology (2020)